Reata Pharmaceuticals, Inc. RETA
172.36 0.00 0.00%
At close · Sep 25
52-week range unavailable
- Open
- 172.34
- Prev close
- 172.36
- Mkt cap
- 6.57B
- Vol
- 1.91M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 172.32
- High
- 172.46
- Forward P/E
- -22.49
- Beta
- 1.37
- Short ratio
- 5.10
- Inst. own
- 101.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 14, 2023
- 50-d avg
- 95.35
- 200-d avg
- 62.81
- 1y target
- 115.30
MAX chart
Chart tools
Chart is warming up
The all-time price history for RETA has not been loaded yet. Try again in a moment.
Altman Z-Score
5.37 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -4.4×
P/S 623×
P/B -21.0×
P/FCF -6.6×
EV/EBITDA -5.4×
EV/Sales 657×
FCF Yield -15.0%
Gross Margin 100.0%
Operating Margin -12191.1%
Net Margin -14075.0%
ROE 474.8%
ROIC -59.0%
ROA -60.6%
Revenue -80.7%
Operating Income -10.4%
EPS (diluted) -4.9%
Free Cash Flow 12.4%
Current Ratio 6.7×
Quick Ratio 6.7×
Debt / Equity -1.8×
Net Debt / EBITDA -0.3×
Interest Coverage -6.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31